# Atlas Bio

Company record · Presspool · https://presspool.ai/companies/atlas-bio

Uses a foundation AI model of human biology to run in silico clinical trials. Website: https://atlas.bio

## Funding

Latest announced financing: $10 million, seed, led by Creandum, announced October 27, 2026.

- **$10 million seed**, announced October 27, 2026. Led by [Creandum](https://presspool.ai/investors/creandum). Listed in the [AI startup funding roster for October 26–31, 2026](https://presspool.ai/ai-startup-funding/week-of-2026-10-26). Sources: [Tech.eu](https://tech.eu/2026/10/27/swiss-startup-atlas-bio-secures-125m-to-tackle-drug-developments-70-failure-rate-and-move-beyond-animal-testing/), [European Biotechnology](https://european-biotechnology.com/latest-news/atlas-bio-launches-with-12-5m-to-eliminate-animal-testing-and-simulate-phase-2-trials).

Of the 75 seed rounds announced in dollars on Presspool's weekly rosters since September 21, 2026, Atlas Bio's $10 million is the joint 21st largest; their median is $7 million.

## Whether AI names Atlas Bio

- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to October 29, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

## Related records

- Closest rounds in the [roster for October 26–31, 2026](https://presspool.ai/ai-startup-funding/week-of-2026-10-26): [ALLOX](https://presspool.ai/companies/allox-bio) (US$10.5 million seed, October 29, 2026), [Northstar Security](https://presspool.ai/companies/northstar-security) ($7 million seed, October 28, 2026), [Lette](https://presspool.ai/companies/lette-ai) ($6.5 million seed, October 26, 2026), [Ravical](https://presspool.ai/companies/ravical-com) ($17 million seed, October 29, 2026), [Nagare Labs](https://presspool.ai/companies/nagarelabs-com) ($5 million seed, October 26, 2026), [Machenta](https://presspool.ai/companies/machenta-com) ($40 million seed, October 27, 2026).
- [Creandum](https://presspool.ai/investors/creandum), which led this round, also led [Machenta](https://presspool.ai/companies/machenta-com) ($40 million seed, October 27, 2026), [Turba Labs](https://presspool.ai/companies/turbalabs-com) ($52 million Seed and Series A, October 6, 2026) and [hosted·ai](https://presspool.ai/companies/hosted-ai) ($19M Seed, March 19, 2026). It is also named as an investor in [Causa Prima](https://presspool.ai/companies/causaprima-com) ($20 million Seed, October 13, 2026), [Scarlet](https://presspool.ai/companies/scarlet-cc) ($50 million Series B, October 12, 2026) and [Procuros](https://presspool.ai/companies/procuros-io) (€20 million Series A, October 6, 2026).

## Sources

- [Tech.eu](https://tech.eu/2026/10/27/swiss-startup-atlas-bio-secures-125m-to-tackle-drug-developments-70-failure-rate-and-move-beyond-animal-testing/)
- [European Biotechnology](https://european-biotechnology.com/latest-news/atlas-bio-launches-with-12-5m-to-eliminate-animal-testing-and-simulate-phase-2-trials)

---

Presspool is a sourced record of AI startup funding. Rounds are listed because they were publicly announced, and no company pays to be listed.

Published by [Jaxon Parrott](https://jaxonparrott.com). Jaxon Parrott coined [Machine Relations](https://machinerelations.ai) in 2024. [AuthorityTech](https://authoritytech.io), which he founded in 2018, is The World's First Machine Relations Agency.

More: [Tracker](https://presspool.ai/) · [Funding](https://presspool.ai/ai-startup-funding) · [Niches](https://presspool.ai/niches) · [Investors](https://presspool.ai/investors) · [Method](https://presspool.ai/method) · [About](https://presspool.ai/about) · [Contact](https://presspool.ai/contact) · [llms.txt](https://presspool.ai/llms.txt)